Abstract
Epoxycarotenoids form a family of about 200 natural pigments present in photosynthetic organisms, fungi, and animal and human tissues. Numerous studies have evidenced that they exert strong antiproliferative, cytotoxic and proapoptotic activities in cancer cells grown in vitro, and that some of them are resorbed per os, suggesting that they may prevent cancer in vivo. This paper presents a comprehensive description of epoxycarotenoids reported up to 2011 (chemical structure, natural sources, human and animal absorption studies, physiological metabolites) and reviews their biological activity in cancer cells grown in vitro (antiproliferative, cytotoxic and pro-apoptotic activities; molecular and pharmacological targets, ability to reverse multidrug resistance, anti-angiogenic activity).
Keywords: Epoxycarotenoid, carotenoid, epoxyxanthophyll, pigment, cancer, MDR, photosynthetic organisms, antiproliferative, cytotoxic, pro-apoptotic.
Current Bioactive Compounds
Title:Epoxycarotenoids and Cancer. Review
Volume: 8 Issue: 2
Author(s): Anne-Laure Gagez, Valerie Thiery, Virginie Pasquet, Jean-Paul Cadoret and Laurent Picot
Affiliation:
Keywords: Epoxycarotenoid, carotenoid, epoxyxanthophyll, pigment, cancer, MDR, photosynthetic organisms, antiproliferative, cytotoxic, pro-apoptotic.
Abstract: Epoxycarotenoids form a family of about 200 natural pigments present in photosynthetic organisms, fungi, and animal and human tissues. Numerous studies have evidenced that they exert strong antiproliferative, cytotoxic and proapoptotic activities in cancer cells grown in vitro, and that some of them are resorbed per os, suggesting that they may prevent cancer in vivo. This paper presents a comprehensive description of epoxycarotenoids reported up to 2011 (chemical structure, natural sources, human and animal absorption studies, physiological metabolites) and reviews their biological activity in cancer cells grown in vitro (antiproliferative, cytotoxic and pro-apoptotic activities; molecular and pharmacological targets, ability to reverse multidrug resistance, anti-angiogenic activity).
Export Options
About this article
Cite this article as:
Gagez Anne-Laure, Thiery Valerie, Pasquet Virginie, Cadoret Jean-Paul and Picot Laurent, Epoxycarotenoids and Cancer. Review, Current Bioactive Compounds 2012; 8 (2) . https://dx.doi.org/10.2174/157340712801784787
DOI https://dx.doi.org/10.2174/157340712801784787 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Differential Gene Expression in the Nucleus Accumbens and Frontal Cortex of Lewis and Fischer 344 Rats Relevant to Drug Addiction
Current Neuropharmacology “Something is Wrong in the Ras Kingdom” - Evidence for the Involvement of p21Ras/MAP Kinase in Autoimmune Diseases
Current Rheumatology Reviews Polymer-Based Drug Delivery Systems, Development and Pre-Clinical Status
Current Pharmaceutical Design The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy
Current Drug Targets Antineoplastic Potential of Medicinal Plants
Recent Patents on Biotechnology Ultrasound-Triggered Immunotherapy for Cancer Treatment: An Update
Current Protein & Peptide Science subject Index To Volume 2
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Development of a High Throughput Drug Screening Assay for the Detection of Changes in Tau Levels - Proof of Concept with HSP90 inhibitors
Current Alzheimer Research Styrene Maleic Acid Neocarzinostatin Treatment for Hepatocellular Carcinoma
Current Medicinal Chemistry - Anti-Cancer Agents Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools
Protein & Peptide Letters Women Tipping the Scale During Pregnancy: A Special Population for Obesity Interventions,Treatments and Clinical Trials
Current Pharmaceutical Design Nasal Polyposis: From Pathogenesis to Treatment, An Update
Inflammation & Allergy - Drug Targets (Discontinued) Recent Progress in Biological Activities of Indole and Indole Alkaloids
Mini-Reviews in Medicinal Chemistry Pulmonary Defence Mechanisms
Current Respiratory Medicine Reviews “Endothelial Progenitor Cells” as a Therapeutic Strategy in Cardiovascular Disease
Current Vascular Pharmacology Cyclotides, a Novel Ultrastable Polypeptide Scaffold for Drug Discovery
Current Pharmaceutical Design Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad
Current Drug Targets Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Antiviral Agents in the Prevention and Treatment of Virus-Induced Diabetes
Anti-Infective Agents in Medicinal Chemistry CD4+CD25+ Regulatory T-Cell Therapy for Allergy, Autoimmune Disease and Transplant Rejection
Inflammation & Allergy - Drug Targets (Discontinued)